Ignite Creation Date:
2024-05-06 @ 8:01 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06220487
Status:
RECRUITING
Last Update Posted:
2024-01-24
First Post:
2023-12-03
Brief Title:
A Single-arm Open-label Study of Olverembatinib CD3CD19 Bispecific T-cell Engager and Chidamide in Patients With Newly Diagnosed PhALL
Sponsor:
Nanfang Hospital Southern Medical University
Organization:
Nanfang Hospital Southern Medical University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-03
First Submit QC Date:
January 21 2024
Study First Post Date:
2024-01-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-21
Last Update Post Date:
2024-01-24
Last Update Post Date Type:
ACTUAL